CANAGLIFLOZIN ANHYDROUS Pharmacologic Class Indexing
- Class set ID
- c255ffd2-e3fb-4226-bc26-d6d50ad811c7
- Version
- 3
- Effective date
- 20180813
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
Label, Manufacturer, Effective table| Label | Manufacturer | Effective | SPL version |
|---|
| These highlights do not include all the information needed to use INVOKANA safely and effectively. See full prescribing information for INVOKANA. INVOKANA ® (canagliflozin) tablets, for oral use Initial U.S. Approval: 2013 | Cardinal Health 107, LLC | 20260217 | 14 |
| These highlights do not include all the information needed to use INVOKAMET or INVOKAMET XR safely and effectively. See full prescribing information for INVOKAMET or INVOKAMET XR. INVOKAMET ® (canagliflozin and metformin hydrochloride) tablets, for oral use INVOKAMET ® XR (canagliflozin and metformin hydrochloride) extended-release tablets, for oral use Initial U.S. Approval: 2014 | Janssen Pharmaceuticals, Inc. | Janssen Pharmaceuticals Inc | Patheon Puerto Rico, Inc. | PHAST Gesellschaft für Pharmazeutische Qualitätsstandards mbH | Janssen Pharmaceutica NV | Ajinomoto OmniChem | Farmhispania | Rolabo Outsourcing S.L. (Spain) | Janssen Cilag SpA | Johnson & Johnson Private Limited (Mumbai) | Janssen Ortho LLC | Granules India Limited | 20250821 | 31 |
| These highlights do not include all the information needed to use INVOKANA safely and effectively. See full prescribing information for INVOKANA. INVOKANA ® (canagliflozin) tablets, for oral use Initial U.S. Approval: 2013 | Janssen Pharmaceuticals, Inc. | AndersonBrecon Inc. | Ajinomoto OmniChem | Janssen Pharmaceutica NV | Janssen Cilag SpA | Janssen-Ortho LLC | 20250320 | 31 |
| These highlights do not include all the information needed to use INVOKANA safely and effectively. See full prescribing information for INVOKANA. INVOKANA ® (canagliflozin) tablets, for oral use Initial U.S. Approval: 2013 | A-S Medication Solutions | 20231215 | 9 |
| These highlights do not include all the information needed to use INVOKANA safely and effectively. See full prescribing information for INVOKANA. INVOKANA ® (canagliflozin) tablets, for oral use Initial U.S. Approval: 2013 | A-S Medication Solutions | 20231215 | 9 |
| These highlights do not include all the information needed to use INVOKANA safely and effectively. See full prescribing information for INVOKANA. INVOKANA ® (canagliflozin) tablets, for oral use Initial U.S. Approval: 2013 | A-S Medication Solutions | 20231024 | 5 |